Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

NCT06584630 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT06584630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06584630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
December 31, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer